Combination of BEZ235 and Metformin Has Synergistic Effect on Cell Viability in Colorectal Cancer Cells

Patients with type II diabetes mellitus are more susceptible to colorectal cancer (CRC) incidence than non-diabetics. The anti-diabetic drug metformin is most commonly prescribed for the treatment of this disease and has recently shown antitumor effect in preclinical studies. The aberrant mutational...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Taewan, Kim, Taehyung, Choi, Soonyoung, Ko, Hyeran, Park, Deokbae, Lee, Youngki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Developmental Biology 2018
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048307/
https://www.ncbi.nlm.nih.gov/pubmed/30023463
http://dx.doi.org/10.12717/DR.2018.22.2.133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048307/
https://www.ncbi.nlm.nih.gov/pubmed/30023463
http://dx.doi.org/10.12717/DR.2018.22.2.133

Ejemplares similares